Clinical Trial Update: Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating megestrol acetate plus LNG-IUS for endometrial hyperplasia with atypical hyperplasia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia with Atypical Hyperplasia

Drugs mentioned

• Levonorgestrel-releasing intrauterine system (LNG-IUS) (Levonorgestrel-releasing intrauterine system)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Fudan University | Conditions: Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED